细胞内膜网膜压力与肝癌的预后之间的联系
Ming Wu1, Jinxing Yan1, Shimei Qin1
1College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China.
Bioengineering (Basel, Switzerland)
|November 27, 2024
概括
细胞内膜网膜 (ER) 的压力会影响癌症的进展. 一个新的ER与压力相关的基因模型预测肝细胞癌 (HCC) 的预后,并为高风险患者确定Sorafenib等潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 以错误折叠的蛋白质积累为特征的内质网膜 (ER) 压力,与癌症发病有关,影响细胞存活,增殖和转移.
- 与ER压力相关的基因 (ERG) 是各种恶性瘤的潜在治疗点.
- 肝细胞癌 (HCC) 是一个重要的全球健康问题,具有复杂的潜在分子机制.
研究的目的:
- 开发和验证基于ER压力相关基因 (ERG) 的肝细胞癌 (HCC) 的预后模型.
- 确定潜在的治疗策略和与HCC不同风险组相关的药物敏感性.
主要方法:
- 对差异表达的ERG进行查,对HCC的生存有显著影响.
- 使用外部数据集构建和验证预测风险模型.
- 功能丰富分析以确定与风险组相关的途径.
- 评估基因组药物可用性和预测向疗法,包括Sorafenib对ER压力和HCC中自的作用.
主要成果:
- 一个经过验证的基于ERG的预后模型成功地为HCC构建.
- 患者被分为高风险和低风险组,预后不同.
- 功能分析揭示了重要的途径参与,包括未展开的蛋白质反应和DNA修复,区分风险组.
- 索拉芬尼在高危HCC患者中表现出敏感性,可能是通过ER压力诱导的自.
结论:
- 开发的ERG模型准确地预测HCC的预后.
- 该模型提供了对影响患者结果的途径的见解,并提出了新的治疗策略.
- 针对性疗法,如Sorafenib,显示出基于ER压力标记的特定患者亚组的希望.
相关概念视频
01:17Role of ER in the Secretory Pathway
5.3K
Eukaryotic cells have a special pathway that enables communication between various intracellular membrane-bound compartments and also with the extracellular environment. This pathway is termed as the secretory pathway.
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
5.3K
01:31Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
01:32Export of Misfolded Proteins out of the ER
3.5K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.5K
01:37The Unfolded Protein Response
4.4K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.4K
01:19Psychoneuroimmunology: Diabetes and Cancer
24
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
24
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K